CA-NETAPP
14.5.2024 14:02:00 CEST | Business Wire | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced NetApp AIPod with Lenovo ThinkSystem servers for NVIDIA OVX, a converged infrastructure optimized for the generative AI era. NetApp and Lenovo have had a strong partnership for over five years and are now taking the partnership to the next level with the introduction of this simple, cost-effective, and powerful solution for enterprise AI. The new converged infrastructure solution will support NVIDIA NIM inference microservices, the NVIDIA AI Enterprise software platform for generative AI development and deployment, and retrieval-augmented generation (RAG) to enable customers to leverage their private, proprietary data for AI without large-scale model training.
Generative AI has created extensive opportunities for organizations, though many may feel as if AI is out of reach due to the cost, integration complexity, and time to deployment. Meanwhile, pre-built large language models (LLMs) often do not have training on the most up-to-date or relevant data organizations need to generate valuable insights or effectively automate routine tasks.
NetApp has led in unstructured data storage for over three decades, and much of the world’s enterprise unstructured data is stored in NetApp storage. Unlocking the full value of this data requires going far beyond foundational model training. By enabling inferencing and RAG, the NetApp AIPod with Lenovo’s leading server reliability, quality, and performance makes it seamless, simple, and fast to combine the power of LLMs with precise, up-to-date, and pertinent information on NetApp storage.
"The NetApp AIPod with Lenovo ThinkSystem servers for NVIDIA OVX transforms enterprise AI by delivering a pre-integrated, high-performance solution that accelerates the deployment and scaling of generative AI workloads," said Sandeep Singh, Senior Vice President & General Manager, Enterprise Storage at NetApp. "Through our collaboration with NVIDIA and Lenovo, NetApp is empowering organizations to harness the capabilities of AI more efficiently, ensuring that they can focus on creating value and gaining insights from their data without the complexity of building and managing AI infrastructure from scratch."
NetApp AIPod combines NetApp's robust storage systems with hybrid cloud data management, including Lenovo's high-performance ThinkSystem SR675 V3 servers, the leading platforms supporting NVIDIA-certified OVX architecture with NVIDIA L40S GPUs, as well as NVIDIA Spectrum-X Networking, providing a complete and seamless infrastructure solution to streamline AI adoption. Using this solution, customers will be able to conduct AI RAG and inferencing operations for use cases like chatbots, knowledge management, and object recognition. NetApp, in collaboration with Lenovo and NVIDIA, simplifies AI deployment by seamlessly integrating into ecosystems, simplifying operations, accelerating implementation, and safeguarding AI infrastructure, enabling organizations to unlock AI's full potential.
“Lenovo is expanding our partnership with NetApp and NVIDIA to bring the power of AI to every business as part of our continued commitment to enabling and simplifying hybrid AI for our joint customers,” said Kirk Skaugen, President of Lenovo Infrastructure Solutions Group. “As customers deploy AI, they demand business critical availability, ease of management, and infrastructure efficiency. The NetApp AIPod with Lenovo ThinkSystem servers for NVIDIA OVX delivers optimized and validated solutions to make generative AI more accessible for businesses of every size.”
“Making AI accessible and scalable for every industry is more important than ever,” said Bob Pette, Vice President of Enterprise Platforms at NVIDIA. “The NetApp AIPod with Lenovo for NVIDIA OVX offers an AI-ready platform that’s powerful and easy to use, enabling businesses to drive innovation.”
NetApp AIPod with Lenovo for NVIDIA OVX will be available by summer 2024.
Additional Resources
- NetApp AIPodTM with Lenovo for NVIDIA OVX: The Power of Retrieval-Augmented Generation for Every Enterprise
- NetApp Unveils Unified Data Storage Built for the AI Era
- AIPod: Delivering the Promise
About NetApp
NetApp is the intelligent data infrastructure company, combining unified data storage, integrated data services, and CloudOps solutions to turn a world of disruption into opportunity for every customer. NetApp creates silo-free infrastructure, harnessing observability, and AI to enable the industry’s best data management. As the only enterprise-grade storage service natively embedded in the world’s biggest clouds, our data storage delivers seamless flexibility. In addition, our data services create a data advantage through superior cyber resilience, governance, and application agility. Our CloudOps solutions provide continuous optimization of performance and efficiency through observability and AI. No matter the data type, workload, or environment, with NetApp you can transform your data infrastructure to realize your business possibilities. Learn more at www.netapp.com or follow us on X, LinkedIn, Facebook, and Instagram.
NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240514466001/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom